Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4B |
| 2 |
TC Energy
TRP
|
+$1.99B |
| 3 |
Amazon
AMZN
|
+$1.97B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.83B |
| 5 |
NVIDIA
NVDA
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.57B |
| 2 |
Scotiabank
BNS
|
+$1.51B |
| 3 |
Enbridge
ENB
|
+$1.47B |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.02B |
| 5 |
Medtronic
MDT
|
+$871M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 9.2% |
| 3 | Consumer Discretionary | 8.28% |
| 4 | Communication Services | 6.4% |
| 5 | Healthcare | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WSR
3526
DELISTED
Whitestone REIT
WSR
| $5.55M | ﹤0.01% |
451,977
+123,190
| +37% | +$1.55M |
|
|
CCIX
3527
DELISTED
Churchill Capital Corp IX
CCIX
| $5.53M | ﹤0.01% |
528,028
-170,740
| -24% | -$1.8M |
|
|
MRLN
3528
Merlin Inc
MRLN
$429M
| $5.53M | ﹤0.01% |
531,799
-12,164
| -2% | -$126K |
|
3529
Spyre Therapeutics
SYRE
$9.25B
| $5.52M | ﹤0.01% |
329,533
-193,883
| -37% | -$3.16M |
|
3530
World Acceptance Corp
WRLD
$873M
| $5.52M | ﹤0.01% |
32,628
+2,107
| +7% | +$355K |
|
3531
Compass Minerals
CMP
$1.15B
| $5.49M | ﹤0.01% |
285,938
+887
| +0.3% | +$17.6K |
|
3532
Erasca
ERAS
$6.39B
| $5.49M | ﹤0.01% |
2,517,188
+697,339
| +38% | +$1.11M |
|
3533
Emergent Biosolutions
EBS
$248M
| $5.48M | ﹤0.01% |
620,977
+41,585
| +7% | +$323K |
|
3534
ProPetro Holding
PUMP
$1.35B
| $5.46M | ﹤0.01% |
1,042,729
+725,264
| +228% | +$3.85M |
|
3535
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.29B
| $5.44M | ﹤0.01% |
25,668
-31,600
| -55% | -$6.03M |
|
3536
PUT
BridgeBio Pharma
BBIO
$16.5B
| $5.43M | ﹤0.01% |
104,600
-20,400
| -16% | -$995K |
|
3537
International Money Express
IMXI
$367M
| $5.43M | ﹤0.01% |
388,642
+272,041
| +233% | +$3.37M |
|
|
TACH
3538
Titan Acquisition Corp
TACH
$361M
| $5.43M | ﹤0.01% |
+536,082
| New | +$5.42M |
|
|
LBRX
3539
LB Pharmaceuticals
LBRX
$1.38B
| $5.42M | ﹤0.01% |
+343,523
| New | +$5.45M |
|
3540
Trump Media & Technology Group
DJT
$2.83B
| $5.41M | ﹤0.01% |
329,322
-236,286
| -42% | -$4.19M |
|
3541
CALL
NuScale Power
SMR
$4.03B
| $5.4M | ﹤0.01% |
+150,000
| New | +$5.98M |
|
3542
Hallador Energy
HNRG
$696M
| $5.39M | ﹤0.01% |
275,663
+108,093
| +65% | +$1.86M |
|
3543
Fulcrum Therapeutics
FULC
$297M
| $5.39M | ﹤0.01% |
586,351
-557,185
| -49% | -$4.03M |
|
3544
GoodRx Holdings
GDRX
$1.26B
| $5.39M | ﹤0.01% |
1,273,681
+983,641
| +339% | +$4.32M |
|
|
VZLA
3545
Vizsla Silver
VZLA
$1.31B
| $5.38M | ﹤0.01% |
1,246,225
+395,310
| +46% | +$1.37M |
|
3546
CALL
Lowe's Companies
LOW
$125B
| $5.38M | ﹤0.01% |
21,400
| – | – |
|
3547
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.21B
| $5.37M | ﹤0.01% |
56,954
-9,199
| -14% | -$846K |
|
3548
Enliven Therapeutics
ELVN
$4.43B
| $5.37M | ﹤0.01% |
262,272
+72,767
| +38% | +$1.47M |
|
|
SILA
3549
DELISTED
Sila Realty Trust
SILA
| $5.36M | ﹤0.01% |
213,419
+72,735
| +52% | +$1.81M |
|
3550
Diebold Nixdorf
DBD
$2.56B
| $5.36M | ﹤0.01% |
93,915
-65,324
| -41% | -$3.87M |
|
Similar funds
Goldman Sachs's Q3 2025 Portfolio in Review
As of Q3 2025, Goldman Sachs held 6,765 positions worth $817B, up 11% from $736B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Goldman Sachs's Q3 2025 filing shows 707 new, 2,950 increased, 2,106 reduced and 470 closed positions. Its largest new stake was Fidelity Enhanced International ETF: 1,911,687 shares worth $67.4M. The largest sale was iShares Russell 2000 ETF, an estimated $1.57B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Goldman Sachs's largest Q3 2025 buy was Fidelity Enhanced International ETF: 1,911,687 shares worth $67.4M.
- Goldman Sachs added most to Microsoft in Q3 2025, an estimated $4B increase.
- Goldman Sachs's biggest Q3 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $1.57B.
- Goldman Sachs fully exited Ansys in Q3 2025, selling an estimated $564M.
- Goldman Sachs's ten largest holdings make up 22% of its $817B portfolio in Q3 2025.
- Goldman Sachs opened 707 new positions and closed 470 in Q3 2025.
- Goldman Sachs's portfolio value rose 11% quarter-over-quarter to $817B.
Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.